Sickle Cell Disease Treatment Global Market Report 2025

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,490	200 Pages	The Business Research Company	March, 2025	BRC19723757

Best Price Guarantee
Price	from $4,490
Length	200 Pages
Publisher	The Business Research Company
Published Date	March, 2025
SKU	BRC19723757

Sickle Cell Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sickle cell disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for sickle cell disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sickle cell disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Treatment Modality: Blood Transfusion; Pharmacotherapy; Bone Marrow Transplant

2) By Disease Type: Sickle Cell Anemia; Hemoglobin Sickle C Disease (HbSC); Other Disease Types

3) By Route Of Administration: Oral; Parenteral

4) By End-User: Hospitals; Specialty Clinics; Other End-Users

Subsegments:

1) By Blood Transfusion: Regular Blood Transfusion; Exchange Transfusion

2) By Pharmacotherapy: Hydroxyurea; L-Glutamine; Voxelotor; Crizanlizumab

3) By Bone Marrow Transplant: Allogeneic Transplant; Autologous Transplant

Companies Mentioned: Sun Pharmaceutical Industries Ltd.; Pfizer Inc.; Johnson & Johnson Private Limited; Merck & Co Inc.; Novartis AG

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary
2. Sickle Cell Disease Treatment Market Characteristics
3. Sickle Cell Disease Treatment Market Trends And Strategies
4. Sickle Cell Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Sickle Cell Disease Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Sickle Cell Disease Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Sickle Cell Disease Treatment Market Growth Rate Analysis; 5.4. Global Sickle Cell Disease Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Sickle Cell Disease Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Sickle Cell Disease Treatment Total Addressable Market (TAM)
6. Sickle Cell Disease Treatment Market Segmentation: 6.1. Global Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Blood Transfusion; Pharmacotherapy; Bone Marrow Transplant; 6.2. Global Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Sickle Cell Anemia; Hemoglobin Sickle C Disease (HbSC); Other Disease Types; 6.3. Global Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Oral; Parenteral; 6.4. Global Sickle Cell Disease Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospitals; Specialty Clinics; Other End-Users; 6.5. Global Sickle Cell Disease Treatment Market, Sub-Segmentation Of Blood Transfusion, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Regular Blood Transfusion; Exchange Transfusion; 6.6. Global Sickle Cell Disease Treatment Market, Sub-Segmentation Of Pharmacotherapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hydroxyurea; L-Glutamine; Voxelotor; Crizanlizumab; 6.7. Global Sickle Cell Disease Treatment Market, Sub-Segmentation Of Bone Marrow Transplant, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Allogeneic Transplant; Autologous Transplant
7. Sickle Cell Disease Treatment Market Regional And Country Analysis: 7.1. Global Sickle Cell Disease Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Sickle Cell Disease Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Sickle Cell Disease Treatment Market: 8.1. Asia-Pacific Sickle Cell Disease Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Sickle Cell Disease Treatment Market: 9.1. China Sickle Cell Disease Treatment Market Overview; 9.2. China Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Sickle Cell Disease Treatment Market: 10.1. India Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Sickle Cell Disease Treatment Market: 11.1. Japan Sickle Cell Disease Treatment Market Overview; 11.2. Japan Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Sickle Cell Disease Treatment Market: 12.1. Australia Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Sickle Cell Disease Treatment Market: 13.1. Indonesia Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Sickle Cell Disease Treatment Market: 14.1. South Korea Sickle Cell Disease Treatment Market Overview; 14.2. South Korea Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Sickle Cell Disease Treatment Market: 15.1. Western Europe Sickle Cell Disease Treatment Market Overview; 15.2. Western Europe Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Sickle Cell Disease Treatment Market: 16.1. UK Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Sickle Cell Disease Treatment Market: 17.1. Germany Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Sickle Cell Disease Treatment Market: 18.1. France Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Sickle Cell Disease Treatment Market: 19.1. Italy Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Sickle Cell Disease Treatment Market: 20.1. Spain Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Sickle Cell Disease Treatment Market: 21.1. Eastern Europe Sickle Cell Disease Treatment Market Overview; 21.2. Eastern Europe Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Sickle Cell Disease Treatment Market: 22.1. Russia Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Sickle Cell Disease Treatment Market: 23.1. North America Sickle Cell Disease Treatment Market Overview; 23.2. North America Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Sickle Cell Disease Treatment Market: 24.1. USA Sickle Cell Disease Treatment Market Overview; 24.2. USA Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Sickle Cell Disease Treatment Market: 25.1. Canada Sickle Cell Disease Treatment Market Overview; 25.2. Canada Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Sickle Cell Disease Treatment Market: 26.1. South America Sickle Cell Disease Treatment Market Overview; 26.2. South America Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Sickle Cell Disease Treatment Market: 27.1. Brazil Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Sickle Cell Disease Treatment Market: 28.1. Middle East Sickle Cell Disease Treatment Market Overview; 28.2. Middle East Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Sickle Cell Disease Treatment Market: 29.1. Africa Sickle Cell Disease Treatment Market Overview; 29.2. Africa Sickle Cell Disease Treatment Market, Segmentation By Treatment Modality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Sickle Cell Disease Treatment Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Sickle Cell Disease Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Sickle Cell Disease Treatment Market Competitive Landscape And Company Profiles: 30.1. Sickle Cell Disease Treatment Market Competitive Landscape; 30.2. Sickle Cell Disease Treatment Market Company Profiles; 30.2.1. Sun Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
31. Sickle Cell Disease Treatment Market Other Major And Innovative Companies: 31.1. Sanofi S.A.; 31.2. Bristol-Myers Squibb Company; 31.3. AstraZeneca plc; 31.4. Eli Lilly and Company; 31.5. Gilead Sciences Inc.; 31.6. Amgen Inc.; 31.7. Baxter International Inc.; 31.8. Teva Pharmaceutical Industries Ltd.; 31.9. Vertex Pharmaceuticals Incorporated; 31.10. Alnylam Pharmaceuticals Inc.; 31.11. Ionis Pharmaceuticals Inc.; 31.12. Silver Lake Research Corporation0.45; 31.13. Global Blood Therapeutics Inc.; 31.14. Acceleron Pharma Inc.; 31.15. Sangamo Therapeutics Inc.
32. Global Sickle Cell Disease Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Sickle Cell Disease Treatment Market
34. Recent Developments In The Sickle Cell Disease Treatment Market
35. Sickle Cell Disease Treatment Market High Potential Countries, Segments and Strategies: 35.1 Sickle Cell Disease Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Sickle Cell Disease Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Sickle Cell Disease Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer